Literature DB >> 2865527

Adverse drug reaction monitoring: doing it the French way.

N Moore, M Biour, G Paux, E Loupi, B Begaud, F Boismare, R J Royer.   

Abstract

Mesh：

Year:  1985        PMID： 2865527     DOI： 10.1016/s0140-6736(85)90918-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  34 in total

1.  Spontaneous reporting--of what? Clinical concerns about drugs.

Authors:  I R Edwards
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  First results from an intensified monitoring system to estimate drug related hospital admissions.

Authors:  S Schneeweiss; M Göttler; J Hasford; W Swoboda; M Hippius; A K Hoffmann; A K Riethling; J Krappweis
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

3.  Serotonin reuptake inhibitors and hyperprolactinaemia: a case/non-case study in the French pharmacovigilance database.

Authors:  Thierry Trenque; Emmanuelle Herlem; Pascal Auriche; Moustapha Dramé
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

4.  Pharmacovigilance is... Vigilance.

Authors:  I Ralph Edwards; Rachida Soulayamani Bencheikh
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

5.  Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

Authors:  Frantz Thiessard; Emmanuel Roux; Ghada Miremont-Salamé; Annie Fourrier-Réglat; Françoise Haramburu; Pascale Tubert-Bitter; Bernard Bégaud
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  The future of pharmacovigilance: a personal view.

Authors:  I Ralph Edwards
Journal:  Eur J Clin Pharmacol       Date:  2008-01-03       Impact factor: 2.953

7.  Ongoing challenges in pharmacovigilance.

Authors:  Gerald J Dal Pan
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

8.  Pharmacovigilance. The French system.

Authors:  R J Royer
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

9.  Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database.

Authors:  Cécile Pageot; Julien Bezin; Andy Smith; Mickael Arnaud; Francesco Salvo; Françoise Haramburu; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2017-11       Impact factor: 5.606

10.  The role and strategy of ISoP in global pharmacovigilance.

Authors:  Sten Olsson; Mira Harrison-Woolrych
Journal:  Int J Clin Pharm       Date:  2018-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.